+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Ironwood Pharmaceuticals Inc (IRWD) - Financial and Strategic SWOT Analysis Review

Ironwood Pharmaceuticals Inc (IRWD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the analyst to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Ironwood Pharmaceuticals Inc (Ironwood) is a healthcare company engaged in the discovery, development, and commercialization of human therapeutics and innovative gastrointestinal product opportunities. The company’s pipeline products include linaclotide, and vascular or fibrotic programs. Ironwood offers its products under two brands- Linzess and Constella. The company generates a pipeline of early development candidates and discovery research programs in various therapeutic areas which include gastrointestinal (GI), central nervous system (CNS) and allergic disorders. The company’s portfolio includes CNP-104 and IW-3300. It has strategic partnerships with leading pharmaceutical companies such as AbbVie Inc, for the development and commercialization of linaclotide across the globe. The company operates in the US and Switzerland. Ironwood is headquartered in Boston, Massachusetts, the US.

Ironwood Pharmaceuticals Inc Key Recent Developments

  • May 09, 2024: Ironwood Pharmaceuticals Reports First Quarter 2024 Results
  • Apr 25, 2024: Ironwood Pharmaceuticals to Host First Quarter 2024 Investor Update Call
  • Feb 15, 2024: Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results; Achieves 2023 Financial Guidance
  • Nov 09, 2023: Ironwood Pharmaceuticals Reports Third Quarter 2023 Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Ironwood Pharmaceuticals Inc - Key Facts
  • Ironwood Pharmaceuticals Inc - Key Employees
  • Ironwood Pharmaceuticals Inc - Key Employee Biographies
  • Ironwood Pharmaceuticals Inc - Major Products and Services
  • Ironwood Pharmaceuticals Inc - History
  • Ironwood Pharmaceuticals Inc - Company Statement
  • Ironwood Pharmaceuticals Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Ironwood Pharmaceuticals Inc - Business Description
  • R&D Overview
  • Ironwood Pharmaceuticals Inc - Corporate Strategy
  • Ironwood Pharmaceuticals Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Ironwood Pharmaceuticals Inc - Strengths
  • Ironwood Pharmaceuticals Inc - Weaknesses
  • Ironwood Pharmaceuticals Inc - Opportunities
  • Ironwood Pharmaceuticals Inc - Threats
  • Ironwood Pharmaceuticals Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Ironwood Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
  • Ironwood Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
  • Ironwood Pharmaceuticals Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • May 09, 2024: Ironwood Pharmaceuticals Reports First Quarter 2024 Results
  • Apr 25, 2024: Ironwood Pharmaceuticals to Host First Quarter 2024 Investor Update Call
  • Feb 15, 2024: Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results; Achieves 2023 Financial Guidance
  • Nov 09, 2023: Ironwood Pharmaceuticals Reports Third Quarter 2023 Results
  • Apr 10, 2023: Ironwood Pharmaceuticals : Departure of Directors or Certain Officers
  • Feb 02, 2023: Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2022 Investor Update Call
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Analyst
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Ironwood Pharmaceuticals Inc, Key Facts
  • Ironwood Pharmaceuticals Inc, Key Employees
  • Ironwood Pharmaceuticals Inc, Key Employee Biographies
  • Ironwood Pharmaceuticals Inc, Major Products and Services
  • Ironwood Pharmaceuticals Inc, History
  • Ironwood Pharmaceuticals Inc, Subsidiaries
  • Ironwood Pharmaceuticals Inc, Key Competitors
  • Ironwood Pharmaceuticals Inc, Ratios based on current share price
  • Ironwood Pharmaceuticals Inc, Annual Ratios
  • Ironwood Pharmaceuticals Inc, Interim Ratios
  • Ironwood Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
  • Ironwood Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
  • Ironwood Pharmaceuticals Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Ironwood Pharmaceuticals Inc, Performance Chart (2019 - 2023)
  • Ironwood Pharmaceuticals Inc, Ratio Charts
  • Ironwood Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
  • Ironwood Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2018 to YTD 2024

Samples

Loading
LOADING...

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Viatris Inc
  • Takeda Pharmaceutical Co Ltd
  • Endo International Plc
  • Sucampo AG
  • Bausch Health Companies Inc
  • Ardelyx Inc